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Outcome of radiation therapy depends on accurate, robust 
and verified calculations of the planned dose. Monte Carlo 
(MC) is considered as the gold standard for dosimetric 
calculations, however its popularity in a clinical environment 
is still limited. One of the reasons is the typically complex 
procedure of setting the patient models and beam 
parameters. The focus of physical models development in the 
FLUKA [1][2] MC code, since many years, is put on the 
medical area, making it an ideal tool applicable for the 
nuclear medicine and hadron-therapy simulations. It is 
already used in the clinical environment in HIT and CNAO for 
generating Treatment Planning System (TPS) databases and 
offline treatment verification. The aim of this work is to 
present the recent improvements of FLUKA and its Graphical 
User Interface - Flair [3] providing a fully-functional and 
easy-to-use tool for quality assurance (QA) of treatment 
plans for protons, carbon and other light ion species. 
In this study we present the most recent developments, 
based on several re-calculations of complete proton/ion 
treatment plans from different TPS and facilities using Flair 
and FLUKA. FLUKA recently was enhanced with the RBE 
estimator and dedicated PET, prompt-gamma and charged 
particles scoring for beam range verification. To better 
utilize these advantages, Flair facilitates the application of 
the treatment scheme into the simulation procedure. It is 
able to import the CT DICOM images creating the voxel-
phantom geometries based on parameterization according to 
Schneider et al[4]. Flair allows importing the entire 
treatment scheme directly from the RT DICOM files, such as 
RTSTRUCT, RTDOSE and RTPLAN. To better comply with the 
real irradiation settings, Flair incorporates also the basis 
characteristics of the beam delivery system with the minimal 
effort from the user point of view. 
Several comparisons were made between the TPS and the 
FLUKA simulation scheme. The DVH plots for the PTV/OAR 
shows good agreement for the presented cases; some dose 
deposition differences in various tissues are noticeable, 
especially in the end of the ranges of the beam particles. 
FLUKA physical models were thoroughly validated, hence, 
quantification and identification of the discrepancies, 
especially taking into consideration more complex cases – like 
patients/organs with the more heterogeneous structures, 
may bring a great value for the treatment quality. 
Additional, independent re-calculation is always an asset, 
and usage of FLUKA and its efficient graphical user interface 
Flair, can enhance the popularity of the MC in the clinical 
environment for both research and QA purposes. 
The presented results will be used for further work on the 
tool development, assuring the quality of the treatment 
plans and providing the user with the guidelines for the 
treatment plan optimization. 
 
 
Fig: Flair screenshot of the comparison between TPS and 
FLUKA simulations 
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Purpose: We present an improved method to calculate 
patient-specific calibration curves to convert X-ray computed 
tomography (CT) Hounsfield Unit (HU) to relative stopping 
powers (RSP) for proton therapy treatment planning. We 
introduce also an optimization method to improve the spatial 
resolution and the water equivalent thickness (WET) accuracy 
of proton radiographies [1].  
Materials/Methods: By optimizing the HU-RSP calibration 
curve, the difference between a proton radiographic image 
and a digitally reconstructed X-ray radiography (DRR) is 
minimized. The feasibility of this approach has previously 
been demonstrated [2,3]. This scenario assumes that all 
discrepancies between proton radiography and DRR originate 
from uncertainties in the HU-RSP curve. In reality, external 
factors cause imperfections in the proton radiography, such 
as misalignment compared to the DRR and unfaithful 
representation of geometric structures (“blurring”). We 
